WO2009001862A1 - 内臓脂肪蓄積の評価方法 - Google Patents

内臓脂肪蓄積の評価方法 Download PDF

Info

Publication number
WO2009001862A1
WO2009001862A1 PCT/JP2008/061561 JP2008061561W WO2009001862A1 WO 2009001862 A1 WO2009001862 A1 WO 2009001862A1 JP 2008061561 W JP2008061561 W JP 2008061561W WO 2009001862 A1 WO2009001862 A1 WO 2009001862A1
Authority
WO
WIPO (PCT)
Prior art keywords
visceral fat
fat accumulation
evaluating
amino acid
blood
Prior art date
Application number
PCT/JP2008/061561
Other languages
English (en)
French (fr)
Inventor
Takayuki Tanaka
Toshihiko Ando
Hiroshi Yamamoto
Minoru Yamakado
Original Assignee
Ajinomoto Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co., Inc. filed Critical Ajinomoto Co., Inc.
Priority to EP08765835A priority Critical patent/EP2172775A4/en
Priority to JP2009520617A priority patent/JPWO2009001862A1/ja
Publication of WO2009001862A1 publication Critical patent/WO2009001862A1/ja
Priority to US12/644,798 priority patent/US9182407B2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/02—Nutritional disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

　血液中のアミノ酸の濃度を利用して内臓脂肪蓄積の状態を精度よく評価することができる内臓脂肪蓄積の評価方法、内臓脂肪蓄積評価装置、内臓脂肪蓄積評価方法、内臓脂肪蓄積評価システム、内臓脂肪蓄積評価プログラムおよび記録媒体などを提供することを課題とする。本発明にかかる内臓脂肪蓄積の評価方法は、評価対象から採取した血液から、アミノ酸の濃度値に関するアミノ酸濃度データを測定し、測定した評価対象のアミノ酸濃度データに基づいて、評価対象につき内臓脂肪蓄積の状態を評価する。
PCT/JP2008/061561 2007-06-25 2008-06-25 内臓脂肪蓄積の評価方法 WO2009001862A1 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP08765835A EP2172775A4 (en) 2007-06-25 2008-06-25 METHOD OF EVALUATING VISCERAL GREASE ACCUMULATION
JP2009520617A JPWO2009001862A1 (ja) 2007-06-25 2008-06-25 内臓脂肪蓄積の評価方法
US12/644,798 US9182407B2 (en) 2007-06-25 2009-12-22 Method of evaluating visceral fat accumulation, visceral fat accumulation-evaluating apparatus, visceral fat accumulation-evaluating method, visceral fat accumulation-evaluating system, visceral fat accumulation-evaluating program, recording medium, and method of searching for prophylactic/ameliorating substance for visceral fat accumulation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-166219 2007-06-25
JP2007166219 2007-06-25

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/644,798 Continuation US9182407B2 (en) 2007-06-25 2009-12-22 Method of evaluating visceral fat accumulation, visceral fat accumulation-evaluating apparatus, visceral fat accumulation-evaluating method, visceral fat accumulation-evaluating system, visceral fat accumulation-evaluating program, recording medium, and method of searching for prophylactic/ameliorating substance for visceral fat accumulation

Publications (1)

Publication Number Publication Date
WO2009001862A1 true WO2009001862A1 (ja) 2008-12-31

Family

ID=40185675

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/061561 WO2009001862A1 (ja) 2007-06-25 2008-06-25 内臓脂肪蓄積の評価方法

Country Status (4)

Country Link
US (1) US9182407B2 (ja)
EP (1) EP2172775A4 (ja)
JP (3) JPWO2009001862A1 (ja)
WO (1) WO2009001862A1 (ja)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2053395A1 (en) * 2006-08-04 2009-04-29 Ajinomoto Co., Inc. Metabolic syndrome evaluation method, metabolic syndrome evaluation apparatus, metabolic syndrome evaluation method, metabolic syndrome evaluation system, metabolic syndrome evaluation program and recording medium, and method for search for prophylactic/ameliorating substance for metabolic syndrome
WO2010095682A1 (ja) * 2009-02-19 2010-08-26 味の素株式会社 肥満の評価方法
US8244476B2 (en) 2002-12-09 2012-08-14 Ajinomoto Co., Inc. Hepatic disease-evaluating apparatus, hepatic disease-evaluating method, hepatic disease-evaluating system, hepatic disease-evaluating program and recording medium
WO2014168125A1 (ja) * 2013-04-09 2014-10-16 味の素株式会社 生活習慣病指標の評価方法、生活習慣病指標評価装置、生活習慣病指標評価方法、生活習慣病指標評価プログラム、生活習慣病指標評価システム、および情報通信端末装置
US9182407B2 (en) 2007-06-25 2015-11-10 Ajinomoto Co., Inc. Method of evaluating visceral fat accumulation, visceral fat accumulation-evaluating apparatus, visceral fat accumulation-evaluating method, visceral fat accumulation-evaluating system, visceral fat accumulation-evaluating program, recording medium, and method of searching for prophylactic/ameliorating substance for visceral fat accumulation
WO2016056631A1 (ja) * 2014-10-08 2016-04-14 味の素株式会社 評価方法、評価装置、評価プログラム、評価システム、及び端末装置
JP2017122655A (ja) * 2016-01-07 2017-07-13 味の素株式会社 骨格筋面積の評価方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2053405A4 (en) * 2006-08-04 2009-11-11 Ajinomoto Kk METHOD FOR EVALUATING STRESS, STRESS EVALUATION DEVICE, STRESS EVALUATION METHOD, STRESS EVALUATION SYSTEM, STRESS EVALUATION PROGRAM AND RECORDING MEDIUM
JPWO2009054350A1 (ja) * 2007-10-25 2011-03-03 味の素株式会社 耐糖能異常の評価方法、耐糖能異常評価装置、耐糖能異常評価方法、耐糖能異常評価システム、耐糖能異常評価プログラムおよび記録媒体、ならびに耐糖能異常の予防・改善物質の探索方法
JP6260275B2 (ja) 2011-06-30 2018-01-17 味の素株式会社 脂肪肝の評価方法、脂肪肝評価装置、脂肪肝評価方法、脂肪肝評価プログラム、脂肪肝評価システム、および端末装置
WO2013161191A1 (ja) * 2012-04-26 2013-10-31 日本電気株式会社 保健指導対象者選定条件作成支援装置
EP2674762B1 (en) * 2012-06-12 2016-02-10 Nestec S.A. PC-O 42:4 - A biomarker for visceral adiposity
EP2674760A1 (en) * 2012-06-12 2013-12-18 Nestec S.A. PC-O 44:6 - A biomarker for visceral adiposity
ES2567580T3 (es) * 2012-06-12 2016-04-25 Nestec S.A. PC-O 44:4 - Un biomarcador para la adiposidad visceral
JP6927212B2 (ja) 2016-07-08 2021-08-25 味の素株式会社 軽度認知障害又はアルツハイマー型認知症の評価方法
KR102355667B1 (ko) 2016-07-08 2022-01-26 아지노모토 가부시키가이샤 알츠하이머형 인지증의 장래의 발증 리스크의 평가 방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004052191A1 (ja) 2002-12-09 2004-06-24 Ajinomoto Co., Inc. 生体状態情報処理装置、生体状態情報処理方法、生体状態情報管理システム、プログラム、および、記録媒体
WO2006098192A1 (ja) 2005-03-16 2006-09-21 Ajinomoto Co., Inc. 生体状態評価装置、生体状態評価方法、生体状態評価システム、生体状態評価プログラム、評価関数作成装置、評価関数作成方法、評価関数作成プログラムおよび記録媒体

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61126472A (ja) 1984-11-24 1986-06-13 Advance Res & Dev Co Ltd 診断方法
US20040022827A1 (en) * 1997-09-30 2004-02-05 Chugai Seiyaku Kabusiki Kaisha Remedy for hepatopathy
JP2000298131A (ja) 1999-04-14 2000-10-24 Ryuzo Kawamori 前糖尿病状態の検出方法
JP3975279B2 (ja) 1999-11-01 2007-09-12 旭化成ファーマ株式会社 糖尿病予備群の検査方法
US7329489B2 (en) * 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20020009740A1 (en) * 2000-04-14 2002-01-24 Rima Kaddurah-Daouk Methods for drug discovery, disease treatment, and diagnosis using metabolomics
JP4773666B2 (ja) * 2000-04-18 2011-09-14 勝三 川西 内臓脂肪計
EP1311857B1 (en) * 2000-08-21 2006-03-01 Assistance Publique, Hopitaux De Paris Diagnosis method of fibrotic disease using biochemical markers
US6631330B1 (en) * 2000-08-21 2003-10-07 Assistance Publique-Hopitaux De Paris (Ap-Hp) Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers
AU2003227237A1 (en) 2002-03-29 2003-10-13 Asahi Kasei Pharma Corporation Method of detecting mild impaired glucose tolerance or insulin hyposecretion
JPWO2006129513A1 (ja) * 2005-05-30 2008-12-25 味の素株式会社 肝疾患評価装置、肝疾患評価方法、肝疾患評価システム、肝疾患評価プログラムおよび記録媒体
AU2006302031A1 (en) * 2005-10-11 2007-04-19 Tethys Bioscience, Inc. Diabetes-associated markers and methods of use thereof
EP2053395A4 (en) * 2006-08-04 2010-04-21 Ajinomoto Kk METABOLIC SYNDROME EVALUATION PROCEDURES, METABOLIC SYNDROME EVALUATION DEVICE, METABOLIC SYNDROME EVALUATION PROCEDURES, METABOLIC SYNDROME EVALUATION SYSTEM, METABOLIC SYNDROME EVALUATION PROGRAM AND RECORDING MEDIUM AND METHOD FOR SEARCHING FOR A PROPHYLACTIC / soothing SUBSTANCE FOR METABOLIC SYNDROME
KR101542037B1 (ko) * 2006-12-21 2015-08-05 아지노모토 가부시키가이샤 암 상태의 평가 방법, 및 암 평가 장치, 암 평가 방법, 암 평가 시스템, 암 평가 프로그램 및 기록 매체
JPWO2009001862A1 (ja) 2007-06-25 2010-08-26 味の素株式会社 内臓脂肪蓄積の評価方法
CA2690541A1 (en) * 2007-07-17 2009-01-29 Metabolon, Inc. Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same
JPWO2009054350A1 (ja) * 2007-10-25 2011-03-03 味の素株式会社 耐糖能異常の評価方法、耐糖能異常評価装置、耐糖能異常評価方法、耐糖能異常評価システム、耐糖能異常評価プログラムおよび記録媒体、ならびに耐糖能異常の予防・改善物質の探索方法
JP5270684B2 (ja) * 2007-11-02 2013-08-21 メタボロン、インコーポレイテッド 脂肪肝疾患用のバイオマーカー及びその使用方法
JP5255991B2 (ja) 2008-10-24 2013-08-07 株式会社日立製作所 情報処理装置、及びコンピュータプログラム
WO2010095682A1 (ja) 2009-02-19 2010-08-26 味の素株式会社 肥満の評価方法
BRPI1013387A2 (pt) * 2009-03-31 2019-04-16 Metabolon, Inc. biomarcadores relacionados à resistência à insulina e métodos de uso dos mesmos

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004052191A1 (ja) 2002-12-09 2004-06-24 Ajinomoto Co., Inc. 生体状態情報処理装置、生体状態情報処理方法、生体状態情報管理システム、プログラム、および、記録媒体
WO2006098192A1 (ja) 2005-03-16 2006-09-21 Ajinomoto Co., Inc. 生体状態評価装置、生体状態評価方法、生体状態評価システム、生体状態評価プログラム、評価関数作成装置、評価関数作成方法、評価関数作成プログラムおよび記録媒体

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
"Metabolic Syndrome Diagnostic Criteria Review Committee", JOURNAL OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE, vol. 94, 2005, pages 794
FELIG, P.; MARLISS, E. ET AL., DIABETES, vol. 19, 1970, pages 727
FELIG, P.; MARLISS, E. ET AL., NEW ENGL. J. MED., vol. 281, 1969, pages 881
KONO M. ET AL.: "Seikagakuteki Kensa [1] D. Teibunshi Chisso Kagobutsu Kankei Amino acid to Sono Bunkaku", JAPANESE JOURNAL OF CLINICAL MEDICINE, vol. 62, no. 11, 2004, pages 567 - 570 *
METABOLIC SYNDROME SHINDAN KIJUN KENTO IINKAI: "Metabolic Syndrome no Teigi to Shindan Kijun", THE JOURNAL OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE, vol. 94, no. 4, 2005, pages 794 - 809 *
See also references of EP2172775A4
TAKAHASHI M. ET AL.: "Ningen Dock ni Okeru Kessho Amino Acid Sokutei no Yuyosei ni Tsuite 1: Metabolic Syndrome Kenshin", NINGEN DOCK, vol. 21, no. 2, 2006, pages 589 + ABSTR. NO. 2-6-33, XP009139889 *

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8244476B2 (en) 2002-12-09 2012-08-14 Ajinomoto Co., Inc. Hepatic disease-evaluating apparatus, hepatic disease-evaluating method, hepatic disease-evaluating system, hepatic disease-evaluating program and recording medium
EP2053395A4 (en) * 2006-08-04 2010-04-21 Ajinomoto Kk METABOLIC SYNDROME EVALUATION PROCEDURES, METABOLIC SYNDROME EVALUATION DEVICE, METABOLIC SYNDROME EVALUATION PROCEDURES, METABOLIC SYNDROME EVALUATION SYSTEM, METABOLIC SYNDROME EVALUATION PROGRAM AND RECORDING MEDIUM AND METHOD FOR SEARCHING FOR A PROPHYLACTIC / soothing SUBSTANCE FOR METABOLIC SYNDROME
EP2053395A1 (en) * 2006-08-04 2009-04-29 Ajinomoto Co., Inc. Metabolic syndrome evaluation method, metabolic syndrome evaluation apparatus, metabolic syndrome evaluation method, metabolic syndrome evaluation system, metabolic syndrome evaluation program and recording medium, and method for search for prophylactic/ameliorating substance for metabolic syndrome
US9182407B2 (en) 2007-06-25 2015-11-10 Ajinomoto Co., Inc. Method of evaluating visceral fat accumulation, visceral fat accumulation-evaluating apparatus, visceral fat accumulation-evaluating method, visceral fat accumulation-evaluating system, visceral fat accumulation-evaluating program, recording medium, and method of searching for prophylactic/ameliorating substance for visceral fat accumulation
JP5817527B2 (ja) * 2009-02-19 2015-11-18 味の素株式会社 肥満の評価方法、肥満評価装置、肥満評価方法、肥満評価システム、肥満評価プログラム、記録媒体、および情報通信端末装置
WO2010095682A1 (ja) * 2009-02-19 2010-08-26 味の素株式会社 肥満の評価方法
CN102326084A (zh) * 2009-02-19 2012-01-18 味之素株式会社 肥胖的评价方法
JPWO2010095682A1 (ja) * 2009-02-19 2012-08-30 味の素株式会社 肥満の評価方法
JP2020073886A (ja) * 2013-04-09 2020-05-14 味の素株式会社 生活習慣病指標の評価方法
KR20210007053A (ko) 2013-04-09 2021-01-19 아지노모토 가부시키가이샤 생활습관병 지표의 평가 방법, 생활습관병 지표 평가 장치, 생활습관병 지표 평가 방법, 생활습관병 지표 평가 프로그램, 생활습관병 지표 평가 시스템, 및 정보통신 단말장치
JP7347587B2 (ja) 2013-04-09 2023-09-20 味の素株式会社 取得方法、算出方法、糖尿病評価装置、算出装置、糖尿病評価プログラム、算出プログラム、糖尿病評価システム、および端末装置
JPWO2014168125A1 (ja) * 2013-04-09 2017-02-16 味の素株式会社 生活習慣病指標の評価方法、生活習慣病指標評価装置、生活習慣病指標評価方法、生活習慣病指標評価プログラム、生活習慣病指標評価システム、および情報通信端末装置
KR20150140363A (ko) 2013-04-09 2015-12-15 아지노모토 가부시키가이샤 생활습관병 지표의 평가 방법, 생활습관병 지표 평가 장치, 생활습관병 지표 평가 방법, 생활습관병 지표 평가 프로그램 제품, 생활습관병 지표 평가 시스템, 및 정보통신 단말장치
JP7291605B2 (ja) 2013-04-09 2023-06-15 味の素株式会社 取得方法、算出方法、糖尿病評価装置、算出装置、糖尿病評価プログラム、算出プログラム、糖尿病評価システム、および端末装置
KR102204498B1 (ko) * 2013-04-09 2021-01-19 아지노모토 가부시키가이샤 생활습관병 지표의 평가 방법, 생활습관병 지표 평가 장치, 생활습관병 지표 평가 방법, 생활습관병 지표 평가 프로그램 제품, 생활습관병 지표 평가 시스템, 및 정보통신 단말장치
WO2014168125A1 (ja) * 2013-04-09 2014-10-16 味の素株式会社 生活習慣病指標の評価方法、生活習慣病指標評価装置、生活習慣病指標評価方法、生活習慣病指標評価プログラム、生活習慣病指標評価システム、および情報通信端末装置
KR20170066409A (ko) 2014-10-08 2017-06-14 아지노모토 가부시키가이샤 평가 방법, 평가 장치, 평가 프로그램, 평가 시스템, 및 단말 장치
JPWO2016056631A1 (ja) * 2014-10-08 2017-07-27 味の素株式会社 評価方法、評価装置、評価プログラム、評価システム、及び端末装置
KR102500075B1 (ko) * 2014-10-08 2023-02-16 아지노모토 가부시키가이샤 평가 방법, 평가 장치, 평가 프로그램, 평가 시스템, 및 단말 장치
KR20230028566A (ko) 2014-10-08 2023-02-28 아지노모토 가부시키가이샤 평가 방법, 평가 장치, 평가 프로그램, 평가 시스템, 및 단말 장치
WO2016056631A1 (ja) * 2014-10-08 2016-04-14 味の素株式会社 評価方法、評価装置、評価プログラム、評価システム、及び端末装置
KR102614827B1 (ko) * 2014-10-08 2023-12-19 아지노모토 가부시키가이샤 평가 방법, 평가 장치, 평가 프로그램, 평가 시스템, 및 단말 장치
JP2017122655A (ja) * 2016-01-07 2017-07-13 味の素株式会社 骨格筋面積の評価方法

Also Published As

Publication number Publication date
EP2172775A1 (en) 2010-04-07
JP2016029398A (ja) 2016-03-03
EP2172775A4 (en) 2010-12-01
US20100173348A1 (en) 2010-07-08
US9182407B2 (en) 2015-11-10
JPWO2009001862A1 (ja) 2010-08-26
JP2014062910A (ja) 2014-04-10

Similar Documents

Publication Publication Date Title
WO2009001862A1 (ja) 内臓脂肪蓄積の評価方法
WO2011079938A3 (en) System and method for determining the concentration of an analyte in a sample fluid
WO2009054351A1 (ja) 生体状態評価装置、生体状態評価方法、生体状態評価システム、生体状態評価プログラムおよび記録媒体
HK1203622A1 (en) Accurate analyte measurements for electrochemical test strip based on sensed physical characteristic(s) of the sample containing the analyte and derived biosensor parameters
WO2014066913A8 (en) Health diagnostic systems and methods
WO2007126444A3 (en) Analyte monitoring
WO2008063413A3 (en) Gene expression profiling for identification, monitoring, and treatment of lung cancer
WO2011008581A3 (en) Devices, methods, and kits for determining analyte concentrations
WO2008063414A3 (en) Gene expression profiling for identification, monitoring, and treatment of colorectal cancer
WO2008069881A3 (en) Gene expression profiling for identification, monitoring and treatment of melanoma
EP2104336A3 (en) Composition determination device, composition determination method, and program
EP2138841A3 (en) System and method for measuring an analyte in a sample
EP2759259A3 (en) Apparatus and method for measuring stress based on a behavior of a user
WO2007136980A3 (en) Diagnostic test media and methods for the manufacture thereof
EP1953521A3 (en) System and method for detecting onset of structural failure
EP2333542A3 (en) Fill sufficiency method and system
EP2293081A3 (en) Analyzing apparatus and analyzing method
WO2010053800A3 (en) Method and apparatus for visual field monitoring
WO2009079351A3 (en) System level information for system information, paging and measurements
EP2273233A3 (en) Reliability evaluation device, reliability evaluation method, and reliability evaluation program
WO2010080702A3 (en) Gene expression profiling for the identification, monitoring, and treatment of prostate cancer
WO2011070577A3 (en) An ovulation sensing and analyzing system
EP2284526A4 (en) BIOSENSOR SYSTEM, SENSING POINT AND METHOD FOR MEASURING THE CONCENTRATION OF A SUBSTANCE TO BE ANALYZED IN A BLOOD SAMPLE
MX2011013915A (es) Dispositivo de analisis y metodo de analisis.
DE602005025940D1 (de) Verfahren zum testen endokriner substanz in proben

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08765835

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009520617

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008765835

Country of ref document: EP